Best Neurologists for Drug-Resistant Epilepsy in India

Drug-resistant epilepsy is defined clinically as the failure of seizures to come under adequate control after at least two tolerated and appropriately selected antiseizure drug regimens. This threshold, established by the International League Against Epilepsy (ILAE), distinguishes true drug resistance from undertreated or misdiagnosed epilepsy.

Seizures in drug-resistant epilepsy vary widely — from brief lapses in awareness or focal motor jerking to generalized convulsions — and may occur multiple times daily or cluster unpredictably, creating risks of falls, head injury, and aspiration. Associated health risks include memory and attention problems, mood disorders such as anxiety and depression, and in severe or prolonged cases, hypoxic injury or status epilepticus. The nature and frequency of seizures alone are not sufficient to confirm drug-resistant epilepsy without a formal qualified clinical evaluation.

Diagnosis typically begins with a detailed seizure history, a review of all prior antiseizure medications and their dosing adequacy, and identification of the epilepsy syndrome and seizure type using the ILAE classification framework. Key investigations include routine and prolonged video-EEG monitoring — which is central to localising a seizure focus — alongside high-resolution MRI of the brain to detect structural abnormalities such as hippocampal sclerosis, cortical dysplasia, or tumours. Depending on findings, additional tests such as PET, SPECT, neuropsychological assessment, and in some cases stereo-EEG (SEEG) with intracranial electrode placement may be used to map the epileptogenic zone more precisely before any treatment decision is made.

Treatment is tailored to the individual's seizure type, epilepsy syndrome, identified cause, and overall health status, and is best determined after a multidisciplinary team review. Non-procedural options remain an important part of management for many patients, while those with a clearly identified focal seizure origin may be candidates for surgical or device-based interventions. No treatment plan should be initiated without a comprehensive evaluation by a specialist, as outcomes depend heavily on the accuracy of the underlying diagnosis and the suitability of the chosen approach for that individual.

Non-surgical management includes continued optimisation of antiseizure medication regimens — sometimes including newer-generation agents — as well as dietary therapies such as the ketogenic diet or its modified variants, which have established evidence particularly in children and some adults. Neurostimulation devices including vagus nerve stimulation (VNS) and responsive neurostimulation (RNS) offer non-resective options for patients who are not surgical candidates or who have not achieved adequate seizure control through other means. Lifestyle measures such as sleep regulation, alcohol avoidance, and stress management are recommended adjuncts but are not standalone treatments for drug-resistant epilepsy.

Drug-Resistant Epilepsy Management may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.

Drug-resistant epilepsy is evaluated and managed primarily by an epileptologist — a neurologist with subspecialty training in epilepsy — often working within a dedicated epilepsy centre. For patients being assessed for surgery, a multidisciplinary team typically includes a neurosurgeon with epilepsy surgery experience, a neuropsychologist, a neuroradiologist, and a nuclear medicine specialist.

When selecting a provider, it is advisable to look for a comprehensive epilepsy centre accredited or recognised for its epilepsy surgery programme, with an epileptologist who has documented experience in pre-surgical evaluation and access to advanced monitoring such as video-EEG and intracranial recording. Confirm that the team includes multidisciplinary input, clear pathways for post-operative or long-term follow-up, and transparent discussion of realistic outcomes based on your specific seizure type and imaging findings.

Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.

Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.